Cargando…
Prognostic value of myocardial perfusion scintigraphy in asymptomatic patients with diabetes mellitus at high cardiovascular risk: 5-year follow-up of the prospective multicenter BARDOT trial
BACKGROUND: The Basel Asymptomatic High-Risk Diabetics’ Outcome Trial (BARDOT) demonstrated that asymptomatic diabetic patients with an abnormal myocardial perfusion scintigraphy (MPS) were at increased risk of major adverse cardiovascular events (MACEs) at 2-year follow-up. It remains unclear wheth...
Autores principales: | Caobelli, Federico, Haaf, Philip, Haenny, Gianluca, Pfisterer, Matthias, Zellweger, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440314/ https://www.ncbi.nlm.nih.gov/pubmed/33884468 http://dx.doi.org/10.1007/s00259-021-05349-5 |
Ejemplares similares
-
The Prognostic Value and Clinical Use of Myocardial Perfusion
Scintigraphy in Asymptomatic Patients after Percutaneous Coronary
Intervention
por: de Andrade, Larissa Franco, et al.
Publicado: (2018) -
Myocardial Perfusion Scintigraphy after Percutaneous Coronary
Intervention in Asymptomatic Patients: Useful or Futile?
por: Grossman, Gabriel Blacher
Publicado: (2018) -
Coronary artery calcium score and pre-test probabilities as gatekeepers to predict and rule out perfusion defects in positron emission tomography
por: Clerc, Olivier F., et al.
Publicado: (2023) -
Pulmonary transit time of cardiovascular magnetic resonance perfusion scans for quantification of cardiopulmonary haemodynamics
por: Segeroth, Martin, et al.
Publicado: (2023) -
Myocardial Perfusion Scintigraphy: Techniques, Interpretation, Indications and Reporting
por: Fathala, Ahmed
Publicado: (2011)